human
activ
led
global
dispers
heavi
metal
like
cadmium
mercuri
environ
henc
heavi
metal
pollut
attain
high
visibl
public
arena
increasingli
becom
major
scientif
concern
earli
studi
address
effect
rel
higher
dose
relev
popul
despit
intens
recent
studi
regard
immun
system
target
heavi
metal
inconsist
evolv
especi
regard
effect
lowdos
exposur
report
impair
rang
minor
insidi
transit
chang
occasion
death
expos
subject
variat
suscept
attribut
genet
variabl
varieti
methodolog
regim
metal
form
durat
exposur
dosag
appli
well
activ
cell
biolog
indic
readout
system
use
evalu
chang
elicit
rule
cytokin
import
agent
detect
modul
immun
system
due
sensit
modul
lower
dose
arm
immun
system
measur
cytokin
solubl
mediat
involv
immun
regul
focu
research
three
decad
sever
report
quantif
evergrow
number
analyt
singl
reaction
vessel
emerg
use
fluorescentlabel
microspher
protein
bead
array
pba
base
assay
import
assess
cytokin
evidenc
fact
form
basi
sophist
cellular
commun
network
normal
well
modul
immun
respons
experi
use
isol
human
cell
cytokin
gene
knockout
mice
proven
use
evalu
regul
immunocompet
cell
respons
infect
follow
exposur
heavi
metal
central
regulatori
agent
helper
th
cell
known
differenti
least
two
subset
mice
human
cell
secret
differ
overlap
set
cytokin
common
precursor
secret
cytokin
includ
cell
produc
low
level
human
cell
differenti
believ
consequ
sever
cellular
influenc
cytokin
milieu
differenti
cell
requir
presenc
cell
respons
warrant
presenc
moreov
type
crossregul
varieti
way
domin
one
subset
result
either
predominantli
cellular
antibodi
respons
therefor
inclin
balanc
indic
cytokin
profil
chang
andor
cytokinedepend
regulatori
pathway
often
consid
evalu
heavi
metalmedi
immunomodul
risk
assess
studi
recent
year
fruit
definit
new
th
subset
includ
cell
treg
cell
includ
among
other
constitut
treg
cell
type
regulatori
cell
cell
character
product
high
level
recent
studi
experiment
autoimmun
encephalomyel
adjuvantinduc
arthriti
point
import
cell
optim
recip
differenti
remain
far
unclear
yet
togeth
group
cytokin
produc
lpsactiv
dc
name
favor
differenti
cytokin
seem
share
induc
maintain
differ
th
cell
subset
eg
due
unit
like
addit
induct
known
import
surviv
cell
heterodimer
compos
coval
link
proinflammatori
cytokin
produc
mostli
phagocyt
cell
degre
b
cell
consid
date
critic
factor
skew
immun
respons
toward
type
therebi
exert
substanti
stimulatori
influenc
host
respons
intracellular
pathogen
howev
clue
synergi
support
longterm
prolifer
matur
rest
neonat
cell
cell
transient
increas
product
cytokin
human
cell
clone
present
studi
conduct
examin
relationship
heavi
metalinduc
profil
modif
accompani
respons
cultur
human
peripher
blood
mononuclear
cell
pbmc
end
two
pathway
cell
activ
adopt
either
monoclon
antibodi
mab
heatkil
salmonella
enterica
serovar
enteritidi
hkse
furthermor
associ
skew
vivo
immun
respons
also
investig
balbc
mice
expos
heavi
metal
pathogenfre
environ
order
test
metal
effect
protein
well
mrna
level
evalu
relev
variou
traditionallyus
method
cytokin
assess
elisa
cytometr
beadbas
array
cba
rtpcr
cell
use
studi
isol
buffi
coat
healthi
blood
donor
blood
bank
leipzig
univers
clinic
germani
experi
approv
local
author
inform
consent
particip
subject
obtain
ficol
paqu
amersham
bioscienc
freiburg
germani
densiti
gradient
centrifug
g
appli
separ
pbmc
cell
final
wash
isoton
phosphatebuff
salin
invitrogen
karlsruh
germani
analysi
human
pbmc
subset
perform
use
surfac
marker
stain
flow
cytometri
previous
describ
briefli
set
mab
surfac
antigen
use
bd
bioscienc
heidelberg
germani
control
pe
lymphocyt
gate
forwardsid
scatter
plot
variou
cell
subset
estim
isol
human
pbmc
suspend
hybridom
dif
medium
biochrom
berlin
germani
contain
gentamycin
streptomycin
uml
penicillin
fc
hyclon
laboratori
logan
ut
usa
incub
final
cultur
mlwell
microtit
plate
greiner
bioon
gmbh
germani
cell
activ
agonist
mous
ortho
biotech
bridgewat
nj
usa
clone
mous
beckmancoult
krefeld
germani
clone
trinova
biochem
germani
mab
ngml
hkse
cfuml
ade
salmovac
impfstoffwerk
dessautornau
rosslau
germani
cd
acet
hg
chlorid
sigma
steinheim
germani
dissolv
deioniz
water
stock
solut
gl
immedi
applic
serial
dilut
made
use
cultur
medium
ad
cultur
plate
constitut
final
concentr
cd
hg
rang
ng
control
sampl
establish
cell
receiv
either
mab
hkse
vital
respons
human
pbmc
mab
hkse
evalu
mtt
reduct
test
previous
report
follow
incub
cytokin
level
determin
cultur
media
commerci
avail
elisa
kit
kit
bd
bioscienc
lower
detect
limit
pgml
previous
describ
femal
wildtyp
balbc
mice
old
g
purchas
charl
river
sulzfeld
germani
alloc
studi
anim
handl
accord
anim
protect
law
local
author
use
anim
research
upon
receipt
vendor
mice
quarantin
acclimat
week
prior
use
anim
place
filtertop
plastic
cage
per
cage
exposur
room
automat
light
dark
cycl
allow
free
access
food
water
room
maintain
humid
mice
assign
group
mice
inject
intraperiton
everi
third
day
isoton
nacl
solut
control
cd
hg
mgkg
bodi
weight
mice
monitor
daili
food
water
consumpt
sign
morbid
control
mice
sacrif
day
mice
sacrif
follow
week
exposur
heavi
metal
sacrific
blood
sampl
collect
sera
separ
centrifug
sampl
min
serum
cytokin
level
determin
use
cba
procedur
carri
accord
manufactur
instruct
bd
bioscienc
san
jose
ca
modifi
tarnok
et
al
measur
cytokin
use
serum
test
sampl
reduc
use
dilut
sera
briefli
mous
captur
bead
suspens
mix
sampl
mix
bead
transfer
assay
tube
standard
dilut
test
sampl
ad
appropri
tube
pe
detect
reagent
ad
tube
incub
hr
dark
rt
sampl
wash
ml
wash
buffer
centrifug
g
min
final
test
buffer
ml
ad
sampl
analyz
facscalibur
bd
bioscienc
use
suppli
cytomet
setup
bead
softwar
follow
collect
organ
spleen
transfer
ml
rna
ambion
germani
preserv
overnight
thereaft
mg
spleen
homogen
ml
trifast
reagent
peqlab
biotechnologi
erlangen
germani
rna
separ
accord
manufactur
instruct
rna
probe
treat
reagent
ambion
dresden
germani
elimin
genom
dna
revers
transcript
rna
conduct
use
amv
revers
transcriptas
promega
madison
usa
cdna
probe
purifi
use
qiaquick
pcr
purif
kit
qiagen
accord
manufactur
instruct
store
amplif
cdna
perform
lightcycl
use
lightcyclerfaststart
dna
masterplu
sybr
green
roch
mannheim
germani
reaction
mixtur
includ
water
primer
dna
master
mix
cdna
templat
appli
capillari
shortli
centrifug
g
reaction
start
initi
activ
step
min
follow
cycl
start
denatur
step
specif
cycl
condit
appli
valid
specif
primer
pair
product
control
sybr
green
dissoci
curv
agaros
gel
electrophoresi
via
dnasequenc
pcr
product
ensur
singl
targetspecif
product
appropri
length
amplifi
gapdh
chosen
refer
housekeep
gene
show
amplif
effici
similar
cytokin
gene
sequenc
sens
antisens
mous
primer
gapdh
act
aac
atc
aaa
tgg
tcc
aca
atg
cca
aag
ii
ggc
tga
ctg
aac
tca
gat
tga
aca
gtt
ttc
agc
tgt
ata
iii
agc
acg
gca
gca
gaa
ttg
agg
gag
aag
tag
gaa
iv
acc
ccc
agc
tag
ttg
gtg
gtg
ttc
ttc
gtt
cross
point
reaction
determin
use
second
deriv
maximum
algorithm
arithmet
baselin
adjust
use
lightcycl
softwar
softwar
download
use
estim
cytokin
mrna
express
well
downregul
factor
gene
rel
control
base
effici
correct
mathemat
model
pairwis
fix
realloc
random
test
experi
carri
triplic
data
analysi
perform
use
statistica
softwar
statsoft
hamburg
germani
variat
among
cytokin
profil
differ
donor
test
use
nonparametr
anova
kruskalw
test
follow
dunn
posttest
wilcoxon
rank
test
pair
sampl
use
analyz
differ
control
heavi
metaltr
cell
human
pbmc
cultur
correl
cytokin
product
heavi
metal
dose
well
cytokin
pair
analyz
use
spearman
rank
correl
test
unless
otherwis
indic
signific
determin
p
isol
human
pbmc
use
vitro
studi
total
cell
percentag
lymphocyt
monocyt
granulocyt
well
lymphocyt
subpopul
normal
rang
previous
report
profil
mabstimul
pbmc
reveal
exposur
cd
significantli
decreas
releas
p
wilcoxon
test
test
dose
ngml
fig
addit
file
valu
supernat
mabstimul
control
cell
rang
pgml
mean
valu
pgml
inhibit
level
dosedepend
subject
test
spearman
r
valu
rang
p
hand
activ
cell
hkse
significantli
induc
product
cd
dose
rang
ngml
fig
cytokin
level
tend
decreas
increas
cd
level
previous
report
group
consid
mean
test
subject
n
increas
level
reveal
strong
neg
correl
cd
dose
ngml
spearman
r
valu
p
control
cell
activ
hkse
reveal
valu
rang
pgml
mean
sampl
blood
volunt
use
evalu
level
well
proinflammatori
cytokin
follow
exposur
cd
low
moder
dose
result
demonstr
level
increas
significantli
toxic
dose
declin
increas
cd
toxic
recent
report
supernat
mab
hkseactiv
control
cell
reveal
valu
rang
pgml
mean
pgml
mean
respect
similarli
exposur
hg
dose
rang
pg
significantli
decreas
releas
fig
also
dosedepend
manner
spearman
r
rang
p
addit
file
hksestimul
cell
howev
releas
significantli
increas
hg
dose
pgml
decreas
increas
hg
toxic
behavior
secret
posit
correl
level
previous
report
group
case
cell
activ
test
relationship
level
releas
cell
expos
either
cd
hg
indic
posit
correl
tabl
case
signific
correl
evid
correl
test
reveal
spearman
r
valu
rang
stimul
mab
hkse
respect
consid
mean
valu
measur
cytokin
r
valu
rang
emerg
indic
strong
posit
correl
level
cytokin
figur
show
serum
profil
analyz
cba
sera
mice
expos
intraperiton
cd
acet
hg
chlorid
week
repres
plot
control
pbstreat
cdexpos
mice
repres
figur
result
demonstr
follow
exposur
cd
week
level
posit
correl
downregul
cytokin
r
p
turn
neg
correl
cytokin
r
valu
p
r
valu
p
data
shown
although
increas
serum
profil
mice
expos
week
cd
signific
comparison
control
mice
exposur
cd
week
significantli
increas
level
serum
coincid
increas
level
howev
total
examin
mice
releas
induc
case
exposur
cd
acet
fig
cytokin
also
elev
compar
control
mice
case
hgexposur
hand
decreas
level
due
progress
exposur
metal
beyond
first
three
week
significantli
correl
decreas
throughout
exposur
period
r
p
result
rtpcr
reveal
follow
exposur
balbc
mice
salt
cd
hg
mrna
express
significantli
modifi
rel
control
mice
fig
exposur
cd
week
result
signific
increas
gene
express
whilst
exposur
hg
decreas
express
fold
rel
control
signific
differ
level
metal
time
laps
indic
indic
respons
express
mrna
assess
compar
serum
protein
concord
increas
mrna
express
ratio
exposur
cd
result
increas
follow
exposit
respect
similarli
follow
exposur
cd
rel
express
mrna
posit
correl
mrna
r
valu
p
case
hgexpos
mice
hand
exposit
yield
decreas
mrna
increas
mrna
express
rel
control
mice
also
correl
increas
mrna
express
recal
decreas
mrna
hggroup
rel
group
exposur
period
constitut
signific
factor
furthermor
evid
metal
behav
differ
interest
express
mrna
increas
cytokin
gene
evid
follow
exposur
cd
exposur
hg
either
week
caus
increas
mrna
express
rel
control
mice
respect
follow
exposur
hg
mrna
express
ratio
posit
correl
r
valu
p
neg
correl
mrna
r
valu
p
extend
knowledg
heavi
metalelicit
immun
modul
current
studi
conduct
address
modif
profil
relat
immun
respons
previou
report
issu
indic
cd
hginduc
immunomodul
depend
cell
stimul
pathway
moreov
vivo
data
use
balbc
mice
reveal
distinct
pattern
follow
exposur
subleth
dose
cd
acet
hg
chlorid
differ
period
effect
evid
even
low
concentr
metal
insignific
chang
cell
vital
detect
indic
cytokin
may
serv
sensit
indic
heavi
metalinduc
immun
modul
paramet
vital
respons
current
data
indic
synerg
reveal
distinct
pattern
respons
heavi
metal
depend
metal
ion
well
durat
exposur
studi
cytokin
quantifi
elisa
cba
rtpcr
accord
previou
report
three
method
reveal
compar
result
indic
relev
evalu
immun
respons
compar
serum
cytokin
profil
heavi
metalexpos
mice
mrna
express
ratio
reveal
overal
concord
spearman
r
valu
case
p
infer
metal
exert
modulatori
effect
pretranscript
stage
cytokin
product
indic
relev
cba
rtpcr
evalu
modul
howev
evalu
cytokin
pbabas
assay
offer
definit
advantag
includ
quantit
rtpcr
quantit
well
use
refer
housekeep
gene
calibr
even
affect
treatment
anoth
advantag
pba
enzym
immunoassay
eia
elisa
rtpcr
perform
smaller
sampl
volum
measur
multipl
analyt
simultan
singl
sampl
factor
reduc
execut
time
cost
even
add
precis
assay
advantag
sampl
volum
limit
pediatr
diseas
surveil
experi
use
anim
model
therefor
longer
process
time
elabor
sampl
prepar
well
cost
rtpcr
techniqu
quantifi
cytokin
use
pba
offer
great
eas
perform
comparison
elisa
wide
calibr
rang
pba
offer
great
flexibl
moreov
analyz
perform
establish
pba
detect
plasma
ab
reveal
advantag
resolut
weakli
reactiv
sampl
compar
two
eia
western
blot
techniqu
former
abl
offer
high
throughput
eia
combin
individu
protein
test
capac
western
blot
howev
pba
like
assay
limit
one
consist
observ
although
flexibl
user
friendli
costeffect
elisa
still
detect
nonoverlap
paramet
popul
anoth
limit
may
interfer
serum
protein
sampl
reveal
differ
result
measur
differ
titrat
replac
lowsensit
paramet
reliabl
agent
appli
sampl
dilut
may
reliev
problem
use
dilut
serum
sampl
allow
quantif
cytokin
adequ
taken
togeth
pba
may
rank
relev
quantifi
cytokin
anim
experi
immun
surveil
heavi
metalexpos
subject
optim
assay
may
includ
acquir
larg
number
individu
bead
measur
low
ligand
concentr
improv
cost
benefit
rais
reproduc
pba
recent
establish
analyt
workflow
may
offer
possibl
subsequ
populationlevel
analysi
test
hypothes
gener
donorprofil
analysi
therebi
ad
scientif
insight
allow
practic
distinguish
differ
cohort
popul
use
promis
tool
immun
detect
result
describ
consist
previou
report
support
reciproc
interplay
immun
respons
earli
prefer
th
differenti
believ
depend
balanc
respons
respons
profil
infect
model
listeria
leishmania
schistosoma
toxoplasma
infer
induc
immun
respons
inhibit
cell
differenti
similarli
peripher
type
respons
induc
synthesi
implic
mediat
effect
nk
cell
furthermor
found
activ
nk
cell
therefor
administr
revers
heavi
metalinduc
inhibit
host
defens
boost
resist
untreat
mice
mark
elev
profil
similar
effect
elucid
wildtyp
well
ko
ko
balbc
mice
indispens
induct
protect
respons
salmonella
infect
possibl
promot
effector
function
confirm
observ
fulli
differenti
cell
continu
express
function
receptor
loss
transcript
factor
express
develop
cell
augment
factor
constitut
addit
evid
requir
continu
signal
mainten
respons
howev
evid
diminish
role
favor
immun
respons
indic
differenti
either
phenotyp
constitut
simpl
dichotomi
exampl
although
leishmania
major
evok
respons
ko
mice
diminish
respons
observ
mice
follow
infect
l
major
toxoplasma
gondii
accompani
compensatori
respons
furthermor
neither
deplet
ko
mice
neutral
r
ko
mice
affect
corona
viruselicit
type
cytokin
pattern
henc
propos
essenti
gener
respons
virus
may
select
induc
product
even
absenc
cytokin
host
factor
signal
element
eg
may
compens
lack
endogen
determin
th
cell
differenti
viral
infect
recent
found
bacteriallystimul
dc
produc
unless
cultur
also
contain
cell
cytokin
taken
togeth
data
recal
import
compet
rather
cell
prime
per
se
ie
involv
mainten
ongo
respons
rather
part
initi
immunolog
decisionmak
process
current
studi
find
product
depend
cytokin
previous
activ
cell
may
indic
direct
effect
heavi
metal
cytokin
milieu
eg
accord
current
result
infer
close
associ
induct
respons
seem
may
play
central
role
attain
polar
respons
heavi
metalexpos
individu
even
absenc
pathogen
antigen
may
rais
import
target
therapeut
approach
restabil
immun
respons
heavi
metalexpos
individu
overal
consist
previou
report
result
describ
herein
elucid
synerg
cytokin
turn
shown
reciproc
regul
key
may
domin
relev
indic
heavi
metalinduc
immun
modul
moreov
associ
modul
th
cell
differenti
level
support
use
cytokin
target
therapeut
approach
reestablish
normal
balanc
may
modifi
diseas
final
measur
cytokin
cba
seem
relev
costeffect
methodolog
evalu
immun
modul
author
declar
compet
interest
nyah
sole
author
respons
entir
manuscript
